Login
$SDEV
$1.05 +$0.12 (12.9%) Close

Consolidated Balance Sheets (Current Period Unaudited)

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
ASSETS
Cash and cash equivalents
Inventory, net
Accounts receivable, net
Prepaid expenses and other current assets
Current assets, held-for-sale
Current assets, discontinued operations
Total current assets
Operating lease right-of-use assets
Property and equipment, net
Goodwill
Other intangible assets, net
Digital assets, at fair value
Other assets
Other assets, discontinued operations
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Accounts payable
Accrued liabilities
Bridge Loan
Unsecured Convertible Notes, net of discounts
Embedded derivative liability
Secured Convertible Notes, net of discounts
Operating lease liabilities
Current liabilities, discontinued operations
Total current liabilities
Warrant liabilities, at fair value
Operating lease liabilities-non-current
Deferred tax liabilities, net
Total liabilities
Mezzanine (temporary) equity:
Preferred stock, $0.01 par value; 5,000 shares authorized; Series F Preferred Stock; 0 and 1,347 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Stockholders’ equity (deficit):
Preferred stock, $0.01 par value; 5,000,000 shares authorized; Series B Preferred Stock; 0 and 131 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Series B Preferred Stock
Series C Preferred Stock
Series D Preferred Stock
Common stock, $0.01 par value; 5,000,000,000 shares authorized, 50,590,723 and 25,216,436 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Series D Preferred Stock
Total common stock, $0.01 par value; 5,000,000,000 shares authorized, 50,590,723 and 25,216,436 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity (deficit)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support